Jam

Argenx’s VYVGART® demonstrated statistically significant improvements in AChR-Ab seronegative generalized myasthenia gravis (gMG) patients in the ADAPT SERON phase 3 study (p=0.0068). This is the first global Phase 3 study showing benefits across MuSK+, LRP4+, and triple seronegative subtypes. Argenx plans to submit an sBLA to the FDA by the end of 2025 to expand VYVGART’s label. The drug maintained its consistent safety profile. The results position VYVGART as a potential foundational therapy for a broader gMG population.

Willis Towers Watson (WTW) is expanding its Corporate Risk & Broking team in Japan, hiring 22 professionals in 2025. This growth targets Japan’s projected insurance market expansion from JPY11.7 trillion in 2024 to JPY12.7 trillion by 2028. New hires strengthen Risk & Analytics, Reinsurance, Marine, Business Development, and Claims divisions, bringing expertise from firms like Marsh and Tokio Marine. Japan’s significant marine insurance market, representing 11% of the global fleet, is a key focus area.

HUTCHMED (HCM) CEO Dr. Weiguo Su is taking a leave of absence for health reasons. CFO Johnny Cheng has been appointed Acting CEO, retaining his CFO responsibilities. The Board assures that ongoing research, development, and commercial activities will remain on track. Dr. Su expressed confidence in the team’s ability to execute the company’s strategy. Cheng acknowledged Dr. Su’s 20 years of leadership and contributions to HUTCHMED.

Golden Lake Exploration (GOLXF) secured a C$50,000 convertible note with a 10% annual interest rate, maturing on December 31, 2025. The funds will ensure its Jewel Ridge claims remain active through payments to the U.S. Bureau of Land Management. The outstanding capital can be converted into common shares at $0.05 each, subject to a four-month hold. This financing aims to maintain the mining claims but introduces potential shareholder dilution.

Rocket Lab (RKLB) successfully launched its 70th Electron mission, named ‘Live, Laugh, Launch,’ from New Zealand on August 23, 2025. This marks Electron’s 12th mission of the year and highlights Rocket Lab’s rapid launch cadence, following another successful mission less than three weeks prior. The company is preparing to debut its medium-lift reusable rocket, Neutron, expanding its market reach, and will announce its next Electron mission soon. Rocket Lab continues to be a key player in responsive launch solutions for small satellites.

Graphite One Inc. (GPHOF) approved long-term incentive awards for 2025, including stock options, restricted share units (RSUs), and performance share units (PSUs), governed by their Omnibus Plan. The strategic move aims to incentivize the team as Graphite One advances its U.S. graphite supply chain, focusing on the Graphite Creek deposit and an Ohio manufacturing plant for synthetic graphite and battery anode materials, including a recycling facility. The company aims to become a leading American producer, serving the EV battery and energy storage sectors.

Defence Therapeutics (DTCFF) announced a non-brokered private placement to raise up to $1.2 million by offering debenture units priced at $1,000 each. Each unit includes an 8% convertible debenture (convertible at $0.60 per share) maturing in two years and 1,666 common share purchase warrants (exercisable at $0.75 per share for two years). Interest will be paid annually in cash or shares at the company’s discretion. Securities are subject to a four-month hold. The offering aims to fund the company’s antibody-drug conjugate (ADC) programs.

Argo Graphene Solutions will partner with Ceylon Graphene Technologies starting August 1, 2025. Ceylon will supply high-grade graphene oxide paste for construction material applications. Argo will handle mixing and distribution in North America, targeting global expansion. Early data shows significant improvements: 30% compressive strength, 24% tensile strength, and 70% abrasion resistance. The agreement includes a minimum order of 1,000 kg, scaling to 4,000 kg. The two-year term can be extended, with potential for a joint venture.

Rocket Lab is expanding its U.S. semiconductor manufacturing with a $23.9 million award from the Department of Commerce. This investment will double compound semiconductor and space-grade solar cell production, enhancing domestic access to these technologies for spacecraft manufacturers and improving its capacity to quickly deliver integrated spacecraft systems for national security. This initiative is projected to create economic growth across multiple states and fortify the American semiconductor industrial base.

Gray Media (NYSE:GTN) pioneers NEXTGEN TV broadcasting with two key advancements. WVUE FOX8 in New Orleans will air the Saints preseason game in end-to-end native HDR, a U.S. first. Additionally, Gray is the first broadcast group to implement HDR upconversion across all Big Four Network-affiliated NEXTGEN TV stations, enhancing the viewing experience for roughly 37% of U.S. TV households for the upcoming football season. These moves solidify Gray’s technological leadership in the ATSC 3.0 space.